Search Results - Alexandra Leary

Refine Results
  1. 1

    Targeted Therapy in Ovarian Cancer by Marcus Vetter, Alexandra Leary

    Published in healthbook TIMES. Oncology Hematology (2021-06-01)
    Get full text
    Article


  2. 2

    Immune checkpoint inhibitors in ovarian cancer: where do we stand? by Alexandra Leary, David Tan, Jonathan Ledermann

    Published in Therapeutic Advances in Medical Oncology (2021-08-01)
    Get full text
    Article


  3. 3

    Predictive biomarkers of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer by Juan Francisco Grau Béjar, Elisa Yaniz Galende, Catherine Genestie, Félix Blanc-Durand, Audrey Le Formal, Étienne Rouleau, Alexandra Leary

    Published in Therapeutic Advances in Medical Oncology (2026-03-01)
    Get full text
    Article


  4. 4

    False negative rate at 18F-FDG PET/CT in para-aortic lymphnode involvement in patients with locally advanced cervical cancer: impact of PET technology by Sebastien Gouy, Veronika Seebacher, Cyrus Chargari, Marie Terroir, Serena Grimaldi, Anna Ilenko, Amandine Maulard, Catherine Genestie, Alexandra Leary, Patricia Pautier, Philippe Morice, Désirée Deandreis

    Published in BMC Cancer (2021-02-01)
    Get full text
    Article


  5. 5

    Comparison of the biomarkers for targeted therapies in primary extra‐mammary and mammary Paget's disease by Zoran Gatalica, Semir Vranic, Božo Krušlin, Kelsey Poorman, Phillip Stafford, Denisa Kacerovska, Wijendra Senarathne, Elena Florento, Elma Contreras, Alexandra Leary, April Choi, Gino K. In

    Published in Cancer Medicine (2020-02-01)
    Get full text
    Article


  6. 6

    ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1. by Anita K Dunbier, Helen Anderson, Zara Ghazoui, Elena Lopez-Knowles, Sunil Pancholi, Ricardo Ribas, Suzanne Drury, Kally Sidhu, Alexandra Leary, Lesley-Ann Martin, Mitch Dowsett

    Published in PLoS Genetics (2011-04-01)
    Get full text
    Article


  7. 7

    Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group by Gilles Freyer, Anne Floquet, Olivier Tredan, Aurore Carrot, Carole Langlois-Jacques, Jonathan Lopez, Frédéric Selle, Cyril Abdeddaim, Alexandra Leary, Coraline Dubot-Poitelon, Michel Fabbro, Laurence Gladieff, Michele Lamuraglia

    Published in Nature Communications (2024-03-01)
    Get full text
    Article


  8. 8

    Author Correction: Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group by Gilles Freyer, Anne Floquet, Olivier Tredan, Aurore Carrot, Carole Langlois-Jacques, Jonathan Lopez, Frédéric Selle, Cyril Abdeddaim, Alexandra Leary, Coraline Dubot-Poitelon, Michel Fabbro, Laurence Gladieff, Michele Lamuraglia

    Published in Nature Communications (2024-06-01)
    Get full text
    Article


  9. 9

    Prognostic Value of a Joint K‐PD Model With Tumor Size Dynamics and CA‐125 Kinetics in Recurrent Ovarian Cancer Patients: BOLD Phase II GINECO Study by Aurore Carrot, Pauline Corbaux, Olivier Colomban, Coriolan Lebreton, Laurence Gladieff, Olivier Tredan, Frédéric Selle, Cyril Abdeddaim, Alexandra Leary, Véronique D'Hondt, Coraline Dubot, Thibaut Reverdy, Benoit You, Gilles Freyer

    Get full text
    Article


  10. 10

    Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial by Max Piffoux, Alexandra Leary, Philippe Follana, Cyril Abdeddaim, Florence Joly, Sylvie Bin, Maxime Bonjour, Anais Boulai, Celine Callens, Laurent Villeneuve, Marine Alexandre, Verane Schwiertz, Gilles Freyer, Manuel Rodrigues, Benoit You

    Published in Nature Communications (2025-02-01)
    Get full text
    Article


  11. 11

    RAD51 as a biomarker for homologous recombination deficiency in high‐grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test by Claire JH Kramer, Alba Llop‐Guevara, Elisa Yaniz‐Galende, Benedetta Pellegrino, Natalja T terHaar, Andrea Herencia‐Ropero, Nicoletta Campanini, Antonino Musolino, Tjalling Bosse, Alexandra Leary, Violeta Serra, Maaike PG Vreeswijk

    Get full text
    Article


  12. 12

    Circulating Tumor DNA from Ascites as an alternative to tumor sampling for genomic profiling in ovarian cancer patients by Maria Kfoury, Reda El Hazzaz, Claire Sanson, Felix Blanc Durand, Judith Michels, Emeline Colomba Blameble, Roseline Tang, Audrey Le Formal, Elodie Lecerf, Sebastien Gouy, Amandine Maulard, Patricia Pautier, Etienne Rouleau, Alexandra Leary

    Published in Biomarker Research (2023-10-01)
    Get full text
    Article


  13. 13

    Association between Olaparib Exposure and Early Toxicity in BRCA-Mutated Ovarian Cancer Patients: Results from a Retrospective Multicenter Study by Maud Velev, Alicja Puszkiel, Benoit Blanchet, Sixtine de Percin, Nicolas Delanoy, Jacques Medioni, Claire Gervais, David Balakirouchenane, Nihel Khoudour, Patricia Pautier, Alexandra Leary, Zahra Ajgal, Laure Hirsch, François Goldwasser, Jerome Alexandre, Guillaume Beinse

    Published in Pharmaceuticals (2021-08-01)
    Get full text
    Article


  14. 14

    Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid by Cyril Roussel-Simonin, Felix Blanc-Durand, Roseline Tang, Damien Vasseur, Audrey Le Formal, Laure Chardin, Elisa Yaniz, Sébastien Gouy, Amandine Maulard, Stéphanie Scherier, Claire Sanson, Ludovic Lacroix, Sophie Cotteret, Lea Mauny, François Zaccarini, Etienne Rouleau, Alexandra Leary

    Published in Molecular Cancer (2023-11-01)
    Get full text
    Article


  15. 15

    Prediction of homologous recombination deficiency from routine histology with attention-based multiple instance learning in nine different tumor types by Chiara Maria Lavinia Loeffler, Omar S. M. El Nahhas, Hannah Sophie Muti, Zunamys I. Carrero, Tobias Seibel, Marko van Treeck, Didem Cifci, Marco Gustav, Kevin Bretz, Nadine T. Gaisa, Kjong-Van Lehmann, Alexandra Leary, Pier Selenica, Jorge S. Reis-Filho, Nadina Ortiz-Bruechle, Jakob Nikolas Kather

    Published in BMC Biology (2024-10-01)
    Get full text
    Article


  16. 16

    Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer by Etienne Rouleau, Ana Oaknin, Christophe Klein, Alexandra Leary, Sebastien Gouy, Patricia Pautier, Catherine Genestie, Amandine Maulard, Judith Michels, Marco de Bruyn, Emeline Colomba-Blameble, Annechien Plat, Juan Francisco Grau Bejar, Elisa Yaniz Galende, Qinghe Zeng, Audrey Le Formal, Elodie Edmond, Maëva Moreau

    Published in Journal for ImmunoTherapy of Cancer (2024-07-01)
    Get full text
    Article


  17. 17

    Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond <i>SMARCA4</i> Mutations: A Comprehensive Genomic Analysis by Aurélie Auguste, Félix Blanc-Durand, Marc Deloger, Audrey Le Formal, Rohan Bareja, David C. Wilkes, Catherine Richon, Béatrice Brunn, Olivier Caron, Mojgan Devouassoux-Shisheboran, Sébastien Gouy, Philippe Morice, Enrica Bentivegna, Andrea Sboner, Olivier Elemento, Mark A. Rubin, Patricia Pautier, Catherine Genestie, Joanna Cyrta, Alexandra Leary

    Published in Cells (2020-06-01)
    Get full text
    Article


  18. 18

    Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers. by Paul H Cottu, Jacques Bonneterre, Andrea Varga, Mario Campone, Alexandra Leary, Anne Floquet, Dominique Berton-Rigaud, Marie-Paule Sablin, Anne Lesoin, Keyvan Rezai, François M Lokiec, Catherine Lhomme, Jacques Bosq, Alice S Bexon, Erard M Gilles, Stefan Proniuk, Veronique Dieras, David M Jackson, Alexander Zukiwski, Antoine Italiano

    Published in PLoS ONE (2018-01-01)
    Get full text
    Article


  19. 19

    Molecular Landscape of Therapy-related Myeloid Neoplasms in Patients Previously Treated for Gynecologic and Breast Cancers by Sabine Khalife-Hachem, Khalil Saleh, Florence Pasquier, Christophe Willekens, Anthony Tarabay, Leony Antoun, Thomas Grinda, Cristina Castilla-Llorente, Matthieu Duchmann, Cyril Quivoron, Nathalie Auger, Veronique Saada, Suzette Delaloge, Alexandra Leary, Aline Renneville, Ileana Antony-Debre, Filippo Rosselli, Stéphane De Botton, Flore Salviat, Christophe Marzac, Jean-Baptiste Micol

    Published in HemaSphere (2021-09-01)
    Get full text
    Article


  20. 20

    Patterns of genomic instability in > 2000 patients with ovarian cancer across six clinical trials evaluating olaparib by Alan Barnicle, Isabelle Ray-Coquard, Etienne Rouleau, Karen Cadoo, Fiona Simpkins, Carol Aghajanian, Alexandra Leary, Andrés Poveda, Stephanie Lheureux, Eric Pujade-Lauraine, Benoit You, Jonathan Ledermann, Ursula Matulonis, Charlie Gourley, Kirsten M. Timms, Zhongwu Lai, Darren R. Hodgson, Cathy E. Elks, Simon Dearden, Coumaran Egile, Pierre Lao-Sirieix, Elizabeth A. Harrington, Jessica S. Brown

    Published in Genome Medicine (2024-12-01)
    Get full text
    Article


Search Tools: